PRECLINICAL INVESTIGATION OF ALKYLATING AGENTS IN CANCER CHEMOTHERAPY
1969; Wiley; Volume: 163; Issue: 2 Linguagem: Inglês
10.1111/j.1749-6632.1969.tb24914.x
ISSN1749-6632
AutoresAbraham Goldin, Harry B. Wood,
Tópico(s)Carcinogens and Genotoxicity Assessment
ResumoAnnals of the New York Academy of SciencesVolume 163, Issue 2 p. 954-994 PRECLINICAL INVESTIGATION OF ALKYLATING AGENTS IN CANCER CHEMOTHERAPY Abraham Goldin, Abraham Goldin Cancer Chemotherapy National Service Center Chemotherapy, National Cancer Institute Bethesda, Md.Search for more papers by this authorHarry B. Wood Jr., Harry B. Wood Jr. Cancer Chemotherapy National Service Center Chemotherapy, National Cancer Institute Bethesda, Md.Search for more papers by this author Abraham Goldin, Abraham Goldin Cancer Chemotherapy National Service Center Chemotherapy, National Cancer Institute Bethesda, Md.Search for more papers by this authorHarry B. Wood Jr., Harry B. Wood Jr. Cancer Chemotherapy National Service Center Chemotherapy, National Cancer Institute Bethesda, Md.Search for more papers by this author First published: October 1969 https://doi.org/10.1111/j.1749-6632.1969.tb24914.xCitations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume163, Issue2Biological Effects of Alkylating AgentsOctober 1969Pages 954-994 RelatedInformation
Referência(s)